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Background: Lonicera japonica has been studied extensively by scholars at home and abroad, a number of  compounds 
have been isolated from it, which mainly include organic acids and flavonoids. Pharmacological studies have shown that 
Lonicera japonica has antibacterial and gall bladder-protective effects.
Objective: To study the active constituents in Lonicera japonica and the mechanism of  their anti-upper respiratory tract 
infection action in children.
Methods: Compounds were identified by chromatographic methods, and the mechanism of  anti-pediatric upper respiratory 
tract infection action of  Lonicera japonica decoction was studied using experimental animals. 
Results: A total of  four compounds were isolated, after injection of  egg white, toe edema in rats in the control group was 
very obvious, different test concentrations of  Lonicera japonica decoction all inhibited toe edema in rats to some extents, 
the edema was the mildest in the Lonicera japonica decoction high-dose group, which had the strongest inhibitory effect on 
the development of  inflammation, the Lonicera japonica decoction showed certain dose-effect relationship with toe edema 
in rats. In the rat body temperature control experiment, while body temperature of  rats in the blank group had already risen, 
other groups were still able to lower the body temperature of  rats under the action of  test drugs. The severity of  ear edema 
in mice in the blank control group was obvious, with increased thickness which showed significant difference between left 
and right ears. Under test doses, three Lonicera japonica decoction groups all inhibited xylene-induced ear edema in mice. 
Conclusion: Lonicera japonica has an anti-upper respiratory tract infection action in children.
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Introduction
Lonicera japonica is the dried bud or the flower of  ini-
tial blooming of  Lonicera japonica Thunb. in the family 
Caprifoliaceae, it is sweet in taste, cold in nature, and 
has the actions of  clearing away heat and toxic mate-
rials and relieving wind-heat, which is mainly used in 
the treatment of  carbuncle, furunculosis, pharyngitis, 
erysipelas, bloody flux, common wind-heat cold, febrile 
disease, fever, etc.1 As a common Chinese medicinal 
herb, Lonicera japonica has been studied extensively by 
scholars at home and abroad, a number of  compounds 
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have been isolated from it, which mainly include organ-
ic acids, flavonoids, triterpenoid saponins and volatile 
oils2-7. Pharmacological studies have shown that Lon-
icera japonica has antibacterial, antiviral, anti-inflam-
matory, antipyretic, liver and gall bladder-protective, 
anti-oxidative, anti-fertility, anti-platelet aggregation, 
hypolipidemic, anti-allergic and immunoregulatory ef-
fects8-12.
To clarify the active constituents in Lonicera japonica, 
and investigate the mechanism of  anti-pediatric upper 
respiratory tract infection action of  Lonicera japonica, 
in this paper, the active constituents in Lonicera japon-
ica were isolated and purified, and their structures were 
identified. Meanwhile, the anti-inflammatory effect of  




BRUKER AV600 NMR spectrometer (600HZ); Kof-
filer micro melting point apparatus; ESI- Ms (Finnigan, 
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USA); electrospray ionization (ESI) source; column 
chromatography silica gel (200-300 mesh), Qingdao 
Haiyang Chemical Plant .
4 Kg of  dried Lonicera japonica was taken, and extract-
ed separately with an 8-fold amount of  ethanol (95%)
three times, each time lasted 2 h. The ethanol extracts 
were combined, and ethanol was evaporated to give 
Lonicera japonica ethanol extractum.
The extractum was dissolved in distilled water, and ex-
tracted successively with petroleum ether, ethyl acetate 
and n-butanol three times, respectively, extractants were 
evaporated, then the petroleum ether and ethyl acetate 
extracts were taken and subjected separately to silica gel 
column chromatography, and gradient-eluted with pe-
troleum ether-acetone or chloroform-methanol system 
as eluent, after repeated silica gel column chromatog-
raphy, ODS column chromatography and preparative 
chromatography, four compounds were isolated.
Experimental study on the inhibition of  pediatric upper 
respiratory tract infection by Lonicera japonica decoc-
tion
Wistar rats, 200-220 g, Kunming mice, 18-22 g, half  
male and half  female, were purchased from China 
Medical University. Adaptive feeding was continued for 
weeks, and the rats in each group were fasted for 18 h 
before experiment.
Dried Lonicera japonica was taken, and decocted with 
a 6-fold amount of  water three times, decoction times 
were 1, 0.5 and 0.5 h, respectively, the water decoctions 
were then combined, and concentrated to 1.2 g/mL for 
later use. Dexamethasone acetate cream (999 Pi Yan 
Ping), xylene, dry yeast, dexamethasone acetate tablets.
 
Definition
50 rats whose body temperature was in a normal state 
were selected, and randomly divided into five groups, 
Lonicera japonica decoction treatment was adminis-
tered intragastrically at 60, 30 and 15 g/Kg, respective-
ly,  in the treatment groups. Aspirin was administered 
intragastrically at 0.3 g/Kg, in the asprin control group 
and the blank control group was given intragastrically 
an equivalent amount of  distilled water. The rats were 
administered with the above, once daily for 6 consecu-
tive days. On the 6th day after administration, the rats 
were immediately injected with 3 ml of  yeast solution 
(concentration of  20%) at dorsal skin, after inducing 
pyrexia, body temperature of  the rats was measured.
40 Kunming mice were taken, and randomly divided 
into four groups, namely the control group and the 
Lonicera japonica decoction treatment groups (dose as 
above). The decoction was administered once daily for 
5 consecutive days. On the 5th day, 1 h after adminis-
tration, xylene was applied to left ear of  mice to induce 
inflammation, 30 min later, the mice were sacrificed, 
left and right ears of  the same sites were punched with 
a puncher and weighed on an electronic balance. The 
masses of  the left and right ear pieces were recorded, 
and degree of  edema was calculated.
Methods were the same as in 1,2,3. On the 5th day af-
ter intragastric administration, 0.2 ml of  10% fresh egg 
white was injected immediately in the left toe, toe thick-
nesses before and after egg white injection were meas-
ured, and D-value of  edema was calculated.
 
Statistical analysis
Data were expressed as x
—
±s , multi-sample compari-
son was performed by one-way ANOVA, and compar-
ison among groups was performed by t test, statistical 
analysis was done using SPSS 15.0 statistical software.
 
Results
Structural identification of  active constituents in 
Lonicera japonica
Compound 1
Yellow powder, 1H-NMR (300MHZ) δ: 1.08 (3H, d, 
J=6.0 Hz, H-6’’’), 4.41 (1H, brs, H-l’’’), 5.40 (1H, d, 
J=7.0Hz, H-l’’), 6.26 (1H, d, J=1.8 Hz, H-6), 6.43 (1H, 
d, J=1.8 Hz, H-8), 6.87 (1H, d, J=8.5 Hz, H-5’), 7.58 
(IH, H-2’), 7.67 (1H, br.d, J=8.7 Hz, H-6’), 12.54 (1H, 
s, 5-OH); 13C-NMR (ppm) δ: 18.3 (C-6’’’), 67.7(C-6’’), 
68.7 (C-5’’’), 70.2 (C-4’’), 70.5 (C-2’’’), 70.7 (C-3’’’), 72.4 
(C-4’’’), 74.5 (C-2’’), 76.2 (C-3’’), 76.7 (C-5’’), 93.5 (C-
8), 99.2 (C-6), 101.8 (C-1’’), 101.2 (C-1’’’), 104.5 (C-
10), 115.8 (C-2’), 116.7 (C-5’), 121.5 (C-6’), 121.8 (C-
1’), 133.8 (C-3), 145.2 (C-3’), 148.3 (C-4’), 156.4 (C-9), 
156.6 (C-2), 161.8 (C-5), 164.8 (C-7), 177.8 (C-4). After 
comparing the structure of  compound 1 with the liter-
ature13, it was identified as rutin.
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  Compound 2
White needle crystals, 1H-NMR (300MHZ) δ:0.62 (3H, 
s, H-23), 0.73 (3H, s, H-24), 0.89 (3H, s, H-25), 0.92 
(3H, s, H-26), 0.84 (3H, s, H-29), 0.83 (3H, s, H-30), 
1.12 (3H, s, H-27), 3.02 (1H, br.s, 3-OH), 4.25 (1H, m, 
H-3), 5.18 (1H, br.s, H-12); 13C-NMR (ppm) δ: 15.8 
(C-25), 16.5 (C-24), 17.4 (C-26), 18.3 (C-6), 22.3 (C-11), 
23.5 (C-16), 23.8 (C-30), 25.4 (C-27), 27.4 (C-2), 27.7 
(C-15), 28.8 (C-23), 30.4 (C-20), 32.2 (C-7), 32.3 (C-29), 
32.4 (C-21), 33.7 (C-21), 36.5 (C-10), 38.5 (C-1), 38.8 
(C-4), 39.8 (C-8), 41.1 (C-14), 41.5 (C-18), 45.1 (C-19), 
45.2 (C-17),  47.9 (C-9), 54.2 (C-5), 77.4 (C-3), 121.1 (C-
12), 144.3 (C-13), 178.5 (C-28). After comparing with 
the literature14, the structure of  compound 2 was iden-
tified as oleanolic acid.





Yellowish-white powder. 1H-NMR (300MHZ) δ: 0.84 
(3H, t, H-11), 1.28 (2H, q, H-10), 1.53 (2H, t, H-9), 1.97 
(2H, m, H-2), 2.11 (2H, m, H-6), 3.54 (1H, m, H-4), 
3.85 (1H, m, H-5), 4.03 (2H, t, H-8), 5.08 (1H, m, H-3), 
6.14 (1H, d, H-2’), 6.75 (1H, d, H-8’), 7.02 (1H, br.s, 
H-9’), 7.08 (1H, brs, H5’), 7.42 (1H, d, H-3’); 13C-NMR 
(ppm) δ: 173.5 (C-7), 165.7 (C-1’), 148.2 (C-7’), 145.4 
(C-3’), 145.3 (C-6’), 125.8 (C-4’), 121.8 (C-9’), 116.2 
(C-8’), 114.8 (C-2’), 114.3 (C-5’), 73.5 (C-1), 71.4 (C-4), 
69.8 (C-3), 67.2 (C-5), 64.8 (C-8), 37.9 (C-2), 35.7 (C-
6), 30.5 (C-9), 18.2 (C-10), 13.9 (C-11). After identifica-
tion15, compound 3 was confirmed as chlorogenic acid 
butyl ester.
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Yellow powder, positive to hydrochloric acid-magnesi-
um reaction, upon chromatography on the same thin 
layer with quercetin reference substance using three dif-
ferent development systems, Rf  values were all identi-
cal, suggesting that compound 4 was quercetin.




Anti-inflammatory results of  Lonicera japonica 
decoction
Effect of  Lonicera japonica decoction on toe ede-
ma in rats
Results: as seen in Tab. 1, after injection of  egg white, 
toe edema in rats in the control group was very obvi-
ous, different test concentrations of  Lonicera japonica 
decoction all inhibited toe edema in rats to some ex-
tents, the edema was the mildest in the Lonicera japon-
ica decoction high-dose group, which had the strongest 
inhibitory effect on the development of  inflammation. 
Experimental results showed that at test concentrations, 
Lonicera japonica decoction had certain dose-effect re-
lationship with toe edema in rats.




Group 1h 2h 3h 4h 
Control group 1.65±0.23 2.41±0.47 2.72±0.45 2.88±0.28 







Lonicera japonica decoction 
(medium) 1.47±0.27* 1.69±0.22* 2.14±0.29* 2.37±0.26* 
Lonicera japonica decoction (low) 1.53±0.28 1.89±0.53 2.31±0.17 2.55±0.33 
Note: Comparison with the control group, * P<0.05, ** P<0.01 
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Effect of  Lonicera japonica decoction on body 
temperature in rats
The results revealed that compared with the blank con-
trol group, the aspirin group and three dose groups of  
Lonicera japonica decoction could all lower the body 
temperature in rats, 3 h measurement results showed 
that the body temperature of  rats in the blank group 
had already risen, while other groups were still able to 
lower the body temperature of  rats under the action of  
test drugs. 4 h later, body temperature of  rats in each 
group all went up, yet the elevation of  body tempera-
ture was the fastest in the blank control group, indicat-
ing that compared with the blank control group, Lon-
icera japonica decoction could effectively reduce the 
body temperature of  rats, this had an antipyretic effect.




Anti-inflammatory effect of  Lonicera japonica
The severity of  ear edema in mice in the blank con-
trol group was obvious, with increased thickness which 
showed significant difference between left and right 
ears. Under test doses, three Lonicera japonica decoc-
tion inhibited xylene-inducedear edema in test groups 
of  the mice, the inhibitory effect was especially signif-
icant in the high-dose group (P<0.01), suggesting that 
Lonicera japonica decoction had varying degrees of  an-
ti-inflammatory effects. See Fig. 6.
Fig. 6 Effect of Lonicera japonica decoction on ear edema in mice 
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Discussion
As an important common traditional Chinese medicine, 
Lonicera japonica has been gaining much attention 
from physicians over the ages. It was listed as top grade 
in the "Supplementary Records of  Famous Physicians". 
Famous doctor Li Shizhen described Lonicera japonica 
as "twining vine in trees, with purplish stems, and op-
posite leaves. Leaves are similar to Ficus pumila, green, 
with hair. Flowers bloom in March and April, long in 
one cun, with two flowers and two petals in a pedicle, 
one big one small, and long buds. The flowers open 
white then turn yellow two or three days later, together 
creating yellow and white colors, so is named Jin Yin 
Hua".
In this experiment, the ethanol extractum of  Lonic-
era japonica was extracted successively with petroleum 
ether, ethyl acetate and n-butanol three times, respec-
tively, extractants were evaporated, then the petroleum 
ether and ethyl acetate extracts were taken and sub-
jected separately to silica gel column chromatography, 
and gradient-eluted with petroleum ether-acetone or 
chloroform-methanol system as eluent, after repeated 
silica gel column chromatography, ODS column chro-
matography and preparative chromatography, four 
compounds were isolated, namely quercetin, chloro-
genic acid butyl ester, oleanolic acid and rutin.
Studies have shown that Lonicera japonica has anti-in-
flammatory and antibacterial effects, scholars have pub-
lished a lot of  studies and reports. But whether Lonic-
era japonica has an effect on pediatric respiratory tract 
infections, especially on upper respiratory infections 
has not been adequately reported, and its efficacy and 
mechanism of  action are rarely reported.
Pediatric respiratory tract infections are one of  the most 
common diseases of  acute onset in children, common 
symptoms are manifested as fever, aversion to cold, 
nasal congestion, runny nose and sneezing, most are 
complicated by cough, and may accompany vomiting, 
diarrhea,or febrile seizures. The diseases have a high 
incidence, long duration, and are mostly seasonal, and 
especially epidemic at the turn of  winter and spring. In 
the preliminary phase of  the present study, 286 cases 
of  pediatric upper respiratory tract infections over two 
years were collected, the children were aged between 
8-14 years, with 148 boys, and 138 girls. During the 
process of  treatment, in order to verify the therapeutic 
level of  Lonicera japonica on upper respiratory tract in-
fection in children, the children were randomly divided 
into two groups, namely the experimental group and 
the control group, the control group was given chem-
ical medicine (acetaminophen medicine for cold), the 
experiment is published in another paper. The results 
showed that compared with the control group, the cure 
rate and average course of  treatment were similar in the 
143 cases of  children who have taken Lonicera japonica 
decoction, suggesting significant therapeutic effect of  
Lonicera japonica decoction on upper respiratory tract 
infection in children.
During the process of  inflammation, free radicals can 
be produced, adequate amount of  free radicals can kill 
and remove harmful substances, but excessive, highly 
active oxygen radicals can easily damage the structure 
and function of  cell membranes, resulting in the release 
of  some active intracellular enzymes into the blood, 
and even lead to inflammatory edema16.
Conclusion
On the basis of  the clinical application, the present ex-
periment studied the anti-inflammatory effect of  Lon-
icera japonica decoction. Experimental results showed 
that after injection of  egg white, toe edema in rats in 
the control group was very obvious, different test con-
centrations of  Lonicera japonica decoction all inhibited 
toe edema in rats to some extents, the edema was the 
mildest in the Lonicera japonica decoction high-dose 
group, which had the strongest inhibitory effect on the 
development of  inflammation, the Lonicera japonica 
decoction showed certain dose-effect relationship with 
toe edema in rats. In the rat body temperature control 
experiment, while body temperature of  rats in the blank 
group had already risen, other groups were still able to 
lower the body temperature of  rats under the action 
of  test drugs. The severity of  ear edema in mice in the 
blank control group was obvious, with increased thick-
ness which showed significant difference between left 
and right ears. Under test doses, three Lonicera japon-
ica decoction groups all inhibited xylene-induced ear 
edema in mice, the above tests indicate that Lonicera 
japonica decoction has some anti-inflammatory effect, 
which will further explain the inhibition of  pediatric 
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